136 related articles for article (PubMed ID: 15650238)
21. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein.
Zou Y; Wang Y
Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918
[TBL] [Abstract][Full Text] [Related]
22. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
[TBL] [Abstract][Full Text] [Related]
23. HMGA2, but not HMGA1, is overexpressed in human larynx carcinomas.
Palumbo A; De Martino M; Esposito F; Fraggetta F; Neto PN; Valverde Fernandes P; Santos IC; Dias FL; Nasciutti LE; Meireles Da Costa N; Fusco A; Ribeiro Pinto LF
Histopathology; 2018 Jun; 72(7):1102-1114. PubMed ID: 29266325
[TBL] [Abstract][Full Text] [Related]
24. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
25. HMGA2 participates in transformation in human lung cancer.
Di Cello F; Hillion J; Hristov A; Wood LJ; Mukherjee M; Schuldenfrei A; Kowalski J; Bhattacharya R; Ashfaq R; Resar LM
Mol Cancer Res; 2008 May; 6(5):743-50. PubMed ID: 18505920
[TBL] [Abstract][Full Text] [Related]
26. High mobility group A1 is a molecular target for MYCN in human neuroblastoma.
Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Dominici C; Frati L; Screpanti I; Gulino A
Cancer Res; 2005 Sep; 65(18):8308-16. PubMed ID: 16166307
[TBL] [Abstract][Full Text] [Related]
27. The expression of HMGA genes is regulated by their 3'UTR.
Borrmann L; Wilkening S; Bullerdiek J
Oncogene; 2001 Jul; 20(33):4537-41. PubMed ID: 11494149
[TBL] [Abstract][Full Text] [Related]
28. Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.
Chau KY; Manfioletti G; Cheung-Chau KW; Fusco A; Dhomen N; Sowden JC; Sasabe T; Mukai S; Ono SJ
Mol Med; 2003; 9(5-8):154-65. PubMed ID: 14571323
[TBL] [Abstract][Full Text] [Related]
29. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
30. Differential HMGA expression and post-translational modifications in prostatic tumor cells.
Diana F; Di Bernardo J; Sgarra R; Tessari MA; Rustighi A; Fusco A; Giancotti V; Manfioletti G
Int J Oncol; 2005 Feb; 26(2):515-20. PubMed ID: 15645138
[TBL] [Abstract][Full Text] [Related]
31. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas.
De Martino I; Visone R; Wierinckx A; Palmieri D; Ferraro A; Cappabianca P; Chiappetta G; Forzati F; Lombardi G; Colao A; Trouillas J; Fedele M; Fusco A
Cancer Res; 2009 Mar; 69(5):1844-50. PubMed ID: 19223528
[TBL] [Abstract][Full Text] [Related]
32. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
[TBL] [Abstract][Full Text] [Related]
33. Genomic structure and mutational analysis of the human KIF1Balpha gene located at 1p36.2 in neuroblastoma.
Chen YY; Takita J; Chen YZ; Yang HW; Hanada R; Yamamoto K; Hayashi Y
Int J Oncol; 2003 Sep; 23(3):737-44. PubMed ID: 12888911
[TBL] [Abstract][Full Text] [Related]
34. The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma.
Oppenheimer O; Cheung NK; Gerald WL
Mol Cancer Ther; 2007 Apr; 6(4):1300-9. PubMed ID: 17431108
[TBL] [Abstract][Full Text] [Related]
35. The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells?
Pfannkuche K; Summer H; Li O; Hescheler J; Dröge P
Stem Cell Rev Rep; 2009 Sep; 5(3):224-30. PubMed ID: 19551524
[TBL] [Abstract][Full Text] [Related]
36. Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.
Gladson CL; Dennis C; Rotolo TC; Kelly DR; Grammer JR
Am J Pathol; 1997 May; 150(5):1631-46. PubMed ID: 9137089
[TBL] [Abstract][Full Text] [Related]
37. Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays.
Su L; Bryan N; Battista S; Freitas J; Garabedian A; D'Alessio F; Romano M; Falanga F; Fusco A; Kos L; Chambers J; Fernandez-Lima F; Chapagain PP; Vasile S; Smith L; Leng F
Sci Rep; 2020 Nov; 10(1):18850. PubMed ID: 33139812
[TBL] [Abstract][Full Text] [Related]
38. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
39. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
Gross N; Favre S; Beck D; Meyer M
Int J Cancer; 1992 Aug; 52(1):85-91. PubMed ID: 1354203
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
